The biotech Tridek-One strengthens its executive team

Tridek-One, Paris, Octobre 2, 2019The biotech strengthens its executive team

Tridek One, a French biotechnology company specializing in the development of products for the treatment of immune and inflammatory disorders, today announced the strengthening of its management team with the appointments of Regis Olivier to the position of Chief Financial Officer, Dr Jorge Kirilovsky as Chief Scientific Officer and Dr Delphine Joyeux as Chief Development Officer. Delphine, Régis, and Jorge join the Executive Committee of the company.

(more…)

A new headquarter for Tridek-One

Tridek-One, Evry, july 15 2019 – Tridek One, a french biotech company specialized  in the development of products for the treatment of immune disorders, announces today the move of its headquarter to the Genopole in Evry (south suburb of Paris).

Tridek-One annonce la nomination de Philippe Berthon au poste de Directeur Général

Tridek-One, Paris, le 17 juin 2019Tridek One, société de biotechnologie française spécialisée dans le développement de produits pour le traitement de désordres immunitaires, annonce aujourd’hui la nomination du Dr Philippe Berthon au poste de Directeur Général.

Continue reading “Tridek-One annonce la nomination de Philippe Berthon au poste de Directeur Général”